Malini Bakthavatsalam1, Danny Siu-Chun Ng2, Frank Hiu-Ping Lai3, Fang Yao Tang1, Mårten Erik Brelén1,4, Chi Wai Tsang1, Timothy Yuk-Yau Lai1, Carol Yim-Lui Cheung1. 1. Department of Ophthalmology and Visual Sciences, The Chinese University of Hong Kong, 4/F Hong Kong Eye Hospital, 147K Argyle Street, Mongkok, Hong Kong, SAR, China. 2. Department of Ophthalmology and Visual Sciences, The Chinese University of Hong Kong, 4/F Hong Kong Eye Hospital, 147K Argyle Street, Mongkok, Hong Kong, SAR, China. dannyng@cuhk.edu.hk. 3. Department of Ophthalmology, Caritas Medical Centre, New Kowloon, Hong Kong. 4. Department of Ophthalmology, Prince of Wales Hospital, Shatin, Hong Kong.
Abstract
PURPOSE: To evaluate quantitatively the choroidal vascularity in polypoidal choroidal vasculopathy (PCV) and neovascular age-related macular degeneration (AMD) patients compared to healthy controls. METHODS: All eyes underwent swept source optical coherence tomography (OCT), and choroidal images were binarized into blood vessels lumen and stroma. The choroidal vascular index (CVI) was defined as the ratio of luminal area (LA) over total choroidal area of the subfoveal region with a width of 1500 μm. RESULTS: The study included 73 patients with neovascular AMD or PCV with mean ± standard deviation (SD) age of 71.8 ± 9.3 years, which was older than the mean age of 65.1 ± 10.8 years of 72 healthy eyes from control group (p < 0.01). The 44 PCV eyes had significantly higher mean SFCT of 214.23 ± 95.21 μm than neovascular AMD eyes (172.74 ± 96.48 μm, p = 0.03) and greater luminal area (0.23 ± 0.09 mm2 vs. 0.19 ± 0.08 mm2, p = 0.05). After adjusting for age, axial length, and gender in multivariate regression analysis, the SFCT of PCV and neovascular AMD eyes were not significantly different from healthy eyes (195.55 ± 93.11 μm), but the CVI of both PCV (64.94 ± 5.43%, p = 0.01) and neovascular AMD (62.54 ± 5.57%, p = <0.01) were significantly lower than control (68.53 ± 5.91%). CONCLUSION: Despite physiological changes of choroidal vasculature due to aging, the choroidal morphology is different in PCV, neovascular AMD and healthy eyes, which has implication on disease pathogenesis.
PURPOSE: To evaluate quantitatively the choroidal vascularity in polypoidal choroidal vasculopathy (PCV) and neovascular age-related macular degeneration (AMD) patients compared to healthy controls. METHODS: All eyes underwent swept source optical coherence tomography (OCT), and choroidal images were binarized into blood vessels lumen and stroma. The choroidal vascular index (CVI) was defined as the ratio of luminal area (LA) over total choroidal area of the subfoveal region with a width of 1500 μm. RESULTS: The study included 73 patients with neovascular AMD or PCV with mean ± standard deviation (SD) age of 71.8 ± 9.3 years, which was older than the mean age of 65.1 ± 10.8 years of 72 healthy eyes from control group (p < 0.01). The 44 PCV eyes had significantly higher mean SFCT of 214.23 ± 95.21 μm than neovascular AMD eyes (172.74 ± 96.48 μm, p = 0.03) and greater luminal area (0.23 ± 0.09 mm2 vs. 0.19 ± 0.08 mm2, p = 0.05). After adjusting for age, axial length, and gender in multivariate regression analysis, the SFCT of PCV and neovascular AMD eyes were not significantly different from healthy eyes (195.55 ± 93.11 μm), but the CVI of both PCV (64.94 ± 5.43%, p = 0.01) and neovascular AMD (62.54 ± 5.57%, p = <0.01) were significantly lower than control (68.53 ± 5.91%). CONCLUSION: Despite physiological changes of choroidal vasculature due to aging, the choroidal morphology is different in PCV, neovascular AMD and healthy eyes, which has implication on disease pathogenesis.
Authors: Kunal K Dansingani; Lorah T Perlee; Sara Hamon; May Lee; Vinnie P Shah; Richard F Spaide; John Sorenson; James M Klancnik; Lawrence A Yannuzzi; Irene A Barbazetto; Michael J Cooney; Michael Engelbert; Christine Chen; Alex W Hewitt; K Bailey Freund Journal: Ophthalmology Date: 2016-08-06 Impact factor: 12.079
Authors: Lauren A Branchini; Mehreen Adhi; Caio V Regatieri; Namrata Nandakumar; Jonathan J Liu; Nora Laver; James G Fujimoto; Jay S Duker Journal: Ophthalmology Date: 2013-05-09 Impact factor: 12.079
Authors: Jay C Wang; Inês Laíns; Rebecca F Silverman; Lucia Sobrin; Demetrios G Vavvas; Joan W Miller; John B Miller Journal: Transl Vis Sci Technol Date: 2018-12-20 Impact factor: 3.283